|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
Alberta Cancer Board Alberta Cancer Foundation |
|---|---|
| Information provided by: | Alberta Cancer Board |
| ClinicalTrials.gov Identifier: | NCT00156871 |
Purpose
The purpose of this study is to investigate the impact of fatigue in severely affected transplant patients.
| Condition | Intervention |
|---|---|
|
Fatigue |
Behavioral: exercise |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Open Label, Placebo Control, Parallel Assignment, Efficacy Study |
| Official Title: | Individualized Exercise Program for Treatment of Fatigue in Patients After Hematologic Stem Cell Transplant |
| Estimated Enrollment: | 24 |
| Study Start Date: | April 2003 |
| Estimated Study Completion Date: | December 2010 |
Investigates impact of a monitored program in kinesiology lab at the University of Calgary on fatigue in severely affected transplant patients.
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: James Russell, FRCP | 403-521-3706 |
| Canada, Alberta | |
| Tom Baker Cancer Centre | Recruiting |
| Calgary, Alberta, Canada, T2N 4N2 | |
| Contact: Rachel Syme, PhD clinical_trials_tbcc@cancerboard.ab.ca | |
| Principal Investigator: | James Russell | Alberta Cancer Board |
More Information
| Study ID Numbers: | 181710-DRD 16, ACF 717905155 |
| Study First Received: | September 8, 2005 |
| Last Updated: | February 5, 2007 |
| ClinicalTrials.gov Identifier: | NCT00156871 |
| Health Authority: | Canada: Health Canada |
|
transplant fatigue exercise Malignant disease transplant |
|
Signs and Symptoms Fatigue |
